Fabino Enterprises Limited (BOM:543444)
13.10
-0.67 (-4.87%)
At close: Feb 10, 2026
Fabino Enterprises Market Cap
Fabino Enterprises has a market cap or net worth of 28.88 million as of March 6, 2026. Its market cap has decreased by -47.12% in one year.
Market Cap
28.88M
Enterprise Value
44.32M
Revenue
204.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.10
Market Cap Chart
Since January 13, 2022, Fabino Enterprises's market cap has decreased from 84.74M to 28.88M, a decrease of -65.92%. That is a compound annual growth rate of -22.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 28.88M | -12.42% |
| Dec 31, 2025 | 32.97M | -52.28% |
| Dec 30, 2024 | 69.09M | 19.64% |
| Dec 8, 2023 | 57.75M | -14.06% |
| Dec 29, 2022 | 67.20M | -20.69% |
| Jan 13, 2022 | 84.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emmessar Biotech & Nutrition | 123.90M |
| Colinz Laboratories | 110.87M |
| Shamrock Industrial Company | 110.51M |
| Beryl Drugs | 101.23M |
| Unjha Formulations | 93.19M |
| Vivanza Biosciences | 80.00M |
| Ganga Pharmaceuticals | 70.94M |
| Brawn Biotech | 63.73M |